Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada (Q36658811)
Jump to navigation
Jump to search
scientific article published on 29 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada |
scientific article published on 29 February 2016 |
Statements
1 reference
Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada (English)
1 reference
A B Miller
1 reference
C Popadiuk
1 reference
C L Gauvreau
1 reference
M Bhavsar
1 reference
C Nadeau
1 reference
K Asakawa
1 reference
W M Flanagan
1 reference
M C Wolfson
1 reference
A J Coldman
1 reference
S Memon
1 reference
N Fitzgerald
1 reference
J Lacombe
1 reference
29 February 2016
1 reference
1 reference
Suppl 1
1 reference
S56-63
1 reference
1 February 2016
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference